Access BridgeGap Ventures
6
21M
5
3
0.17
1
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Cambridge. The fund was located in North America if to be more exact in United States.
Among the most popular portfolio startups of the fund, we may highlight TangoMe, Cadent Therapeutics, Novel Therapeutic Technologies. Among the most popular fund investment industries, there are Genetics, Therapeutics. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The top activity for fund was in 2012. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Access BridgeGap Ventures, startups are often financed by WR Hambrecht, Translink Capital, Slater Technology Fund. The meaningful sponsors for the fund in investment in the same round are Slater Technology Fund, Qualcomm Ventures. In the next rounds fund is usually obtained by Schooner Capital, Atlas Venture, Thynk Capital, LLC..
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 3
- Exits
- 1
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (5)
- Health Care (5)
- Pharmaceutical (4)
- Therapeutics (4)
- Medical (3) Show 10 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 318M
- Group Appearance index
- 0.33
- Avg. company exit year
- 10
- Avg. multiplicator
- 11.55
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Elicio Therapeutics | 03 Aug 2012 | Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics | Early Stage Venture | 3M | United States, Cambridge, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.